Trial · NCT07887867
A Study to Learn About the Study Medicine Abrocitinib in People With Severe Atopic Dermatitis Who Have Switched From Other Therapies
NCT07887867, Not yet recruiting, Pfizer
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Study to Learn About the Study Medicine Abrocitinib in People With Severe Atopic Dermatitis Who Have Switched From Other Therapies. Trials, record NCT07887867. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07887867
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Study to Learn About the Study Medicine Abrocitinib in People With Severe Atopic Dermatitis Who Have Switched From Other Therapies
- NCT number
- NCT07887867
- Status
- Not yet recruiting
- Enrollment
- 120 participants, estimated
- Lead sponsor
- Pfizer
- Conditions
- Dermatitis, Atopic
- Interventions
- abrocitinib
- First posted
- 2026-10-21
- Last updated
- 2026-10-21
Source ClinicalTrials.gov
Registered outcomes20
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percentage of Participants Achieving Eczema Area and Severity Index (EASI) <7 | Week 24 | |
| Secondary | EASI 90 | Week 4, 12, 24, 52 | Proportion of participants reaching 90% improvement in EASI from baseline |
| Secondary | Change from baseline in Eczema Area and Severity Index (EASI) Score | Baseline, Week 4, 12, 24, 52 | |
| Secondary | Change from baseline in Peak Pruritus-Numeric Rating Scale (PP-NRS) Score | Baseline, Week 4, 12, 24, 52 | |
| Secondary | Percentage of Participants Achieving PP-NRS <=1 | Week 4, 12, 24, 52 | |
| Secondary | Change from baseline in Investigator's Global Assessment (IGA) Score | Week 4, 12, 24, 52 | |
| Secondary | Percentage of Participants Achieving IGA 0-1 | Week 4, 12, 24, 52 | |
| Secondary | Change from baseline in Dermatology Life Quality Index (DLQI) Score | Week 4, 12, 24, 52 | |
| Secondary | Change From Baseline in Patient-Oriented Eczema Measure (POEM) Score | Week 4, 12, 24, 52 | |
| Secondary | Change from baseline in Sleep Disturbance Numeric Rating Scale (SD-NRS) Score | Week 4, 12, 24, 52 |
1 to 10 of 20Source ClinicalTrials.gov
See all 20 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07887867
GET https://conductscience.org/api/trials/v1/NCT07887867/registered